[Virus infected lymphoblasts acting as antigen for the production of heterologous antilymphocyte sera].
D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000096:biosynthesis*; D002478:Cells, Cultured; D006168:Guinea Pigs; D007165:Immunosuppression Therapy; D037102:Lectins; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D011817:Rabbits; D012513:Sarcoma, Experimental / Q000276:immunology; D018139:Simplexvirus / Q000276:immunology*; D013936:Thymidine; D014184:Transplantation, Homologous; D014316:Tritium; D014616:Vaccinia virus / Q000276:immunology*; D014721:Vesicular stomatitis Indiana virus / Q000276:immunology*
D000961:Antilymphocyte Serum; D037102:Lectins; D014316:Tritium; D013936:Thymidine
Virusinfizierte Lymphoblasten als Antigen für die Herstellung von heterologen Antilymphocytenseren.